QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Definitive Healthcare Corp. (DH)

Healthcare

No action
Fundamental
3
Sentiment
3
Technical
4

Do Nothing: 20-day average dollar volume is $503,383.95, roughly one-tenth of the $5,000,000 liquidity floor, and the recent 3-session average of $527,597 is also below the $1,500,000 recent-liquidity floor — so neither a pullback limit into the 1.19-1.20 shelf nor a breakout stop above the 1.32 swing high can be executed at a fair price, despite a fully aligned bullish MA stack, MACD 0.06 > signal 0.05, RSI14 64.5 and ADX14 35.0.

Analysis as of 2026-11-13· more than 2 trading days ago

Company overview

Definitive Healthcare Corp. provides commercial intelligence solutions for the U.S. healthcare industry, offering data on healthcare providers to assist clients in various business processes. The company's platform includes sixteen intelligence modules supporting sales, marketing, clinical research, and strategic planning. Its clients range from biopharmaceutical firms to healthcare IT companies and other entities within the healthcare ecosystem.

Fundamental

fair
Fundamental3
Mixed fundamentals

The company is cash-generative but shrinking, with mixed fundamentals and wide uncertainty due to a potential take-private offer.

Cash-generative but shrinking healthcare data provider: trailing free cash flow of about $24 million, a net cash balance sheet and no going-concern or covenant issues, offset by revenue down 8-9%, customers down 12%, remaining performance obligations down 16% and a fifth consecutive GAAP loss caused almost entirely by $1.37 billion of cumulative goodwill write-offs. Trading near 1.9x EV/adjusted EBITDA on the Class A count with the outcome dominated by a non-binding Advent take-private indication of interest and suspended guidance - mixed fundamentals with unusually wide uncertainty.

Sentiment

fair
Sentiment3
Forming sentiment

Sentiment is mixed with no strong retail or media confirmation, and the outcome is dominated by a potential acquisition.

The dominant driver is the unresolved Advent International non-binding take-private proposal at $1.02/share (confidence: announced, and market-rewarded at disclosure with a ~13% share jump) running through an independent Special Committee process bounded by the 2026-12-31 TRA early-termination waiver deadline, with Q3 2026 results still being digested since 2026-11-05. The media sentiment delta is determinate but flat (baseline polarity_score +0.07 versus scoring +0.04 as returned, ~+0.10 on the de-duplicated on-topic set), Reddit is unmeasured after a 403 block, and the Red-Flag Screen is clean — no severe or moderate flag fired and therefore no cap applies.

Technical

good
Technical4
Constructive technicals

The technical chart is strong with a bullish alignment, but low liquidity prevents actionable trades.

The chart itself is genuinely constructive: price 1.25 (live quote 1.27) sits above the entire reference stack — SMA20 1.15, SMA50 1.05, SMA200 1.02, EMA9 1.20, EMA21 1.14 — with the short averages correctly stacked (EMA9 > EMA21 > SMA20 > SMA50 > SMA200), MACD line 0.06 above signal 0.05 and both above zero, RSI14 64.5, Williams %R -25.9 and ADX14 35.0 confirming a real directional advance off the 2026-10-16 low at 1.00 toward the 2026-11-12 high at 1.32. That earns a 4 rather than a 5 because volume does not confirm: the tape turns over roughly $0.50M per session and has not expanded on the advance, and price is stalling beneath the 1.28-1.32 supply shelf. The trade is then blocked outright by liquidity, not by chart quality — 20-session average dollar volume of about $503K is one-tenth of the $5M floor and the last three completed sessions average about $528K against a $1.5M recent-liquidity floor, so no entry of any kind is executable at a fair price.

You’re looking at 2026-11-13 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.